Insulin glargine and lixisenatide and Lotemax
Determining the interaction of Insulin glargine and lixisenatide and Lotemax and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: loteprednol ophthalmic
Brand name: Alrex, Inveltys, Lotemax, Lotemax SM
Synonyms: Lotemax (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Lotemax (Loteprednol Eye Drops 0.5% and 1%)
- Insulin glargine and lixisenatide-Lotemax (Loteprednol Eye Gel)
- Insulin glargine and lixisenatide-Lotemax (Loteprednol Eye Ointment)
- Insulin glargine and lixisenatide-Lotemax Eye Gel
- Insulin glargine and lixisenatide-Lotemax Eye Ointment
- Insulin glargine and lixisenatide-Lotemax ophthalmic
- Lotemax-Insulin glargine and lixisenatide Subcutaneous
- Lotemax-Insulin glargine, recombinant Subcutaneous
- Lotemax-Insulin glulisine
- Lotemax-Insulin Glulisine (Cartridges and Pens)
- Lotemax-Insulin Glulisine (Vials)
- Lotemax-Insulin glulisine Subcutaneous